VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 8 filers reported holding VERTEX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $240,000 | -33.9% | 1,300 | -35.0% | 0.03% | -30.2% |
| Q2 2022 | $363,000 | -26.2% | 2,000 | -25.9% | 0.04% | -8.5% |
| Q1 2022 | $492,000 | -24.9% | 2,700 | -25.0% | 0.05% | -24.2% |
| Q4 2021 | $655,000 | +134.8% | 3,600 | +140.0% | 0.06% | +63.2% |
| Q3 2021 | $279,000 | – | 1,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 97,000 | $21,301,000 | 0.77% |
| WINTRUST INVESTMENTS LLC | 3,600 | $655,000 | 0.06% |
| GROUP ONE TRADING, L.P. | 127,500 | $27,999,000 | 0.02% |
| SIMPLEX TRADING, LLC | 66,100 | $14,515,000 | 0.02% |
| SG Americas Securities, LLC | 15,000 | $692,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,500 | $2,745,000 | 0.00% |
| JPMORGAN CHASE & CO | 500 | $110,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |